The long QT syndrome.
Molecular Cardiology Laboratories, Fondazione Salvatore Maugeri IRCCS, Via Ferrata, 8 27100 Pavia, Italy. spriori@fsm.it
S G
SG
Priori
R
R
Bloise
L
L
Crotti
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D002304:Cardiac Pacing, Artificial; D027682:Cation Transport Proteins; D004268:DNA-Binding Proteins; D003937:Diagnosis, Differential; D000072237:ERG1 Potassium Channel; D004554:Electric Countershock; D004562:Electrocardiography; D051638:Ether-A-Go-Go Potassium Channels; D020022:Genetic Predisposition to Disease; D006339:Heart Rate; D006801:Humans; D008133:Long QT Syndrome / Q000175:diagnosis / Q000235:genetics / Q000503:physiopathology / Q000628:therapy; D008967:Molecular Biology / Q000379:methods; D015221:Potassium Channels / Q000235:genetics; D024642:Potassium Channels, Voltage-Gated; D013562:Sympathectomy; D013564:Sympathetic Nervous System / Q000503:physiopathology; D015534:Trans-Activators; D000071230:Transcriptional Regulator ERG
D000319:Adrenergic beta-Antagonists; D027682:Cation Transport Proteins; D004268:DNA-Binding Proteins; C072312:ERG protein, human; D000072237:ERG1 Potassium Channel; D051638:Ether-A-Go-Go Potassium Channels; C092509:KCNH6 protein, human; D015221:Potassium Channels; D024642:Potassium Channels, Voltage-Gated; D015534:Trans-Activators; D000071230:Transcriptional Regulator ERG